Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone Bone Metabolism Study in Postmenopausal Women with IFG
NCT00708175Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in impaired fasting glucose (IFG), sponsored by Takeda. Started May 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
impaired fasting glucose (IFG)
Beyond the preview
Go deeper on NCT00708175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708175.